Moleculin Biotech Inc (MBRX)
4.77
+0.13
(+2.80%)
USD |
NASDAQ |
May 31, 16:00
4.78
+0.01
(+0.21%)
After-Hours: 20:00
Moleculin Biotech Shares Outstanding: 2.312M for May 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 01, 2024 | 2.312M |
April 26, 2024 | 2.312M |
March 31, 2024 | 2.312M |
March 22, 2024 | 2.228M |
March 19, 2024 | 2.228M |
March 14, 2024 | 2.228M |
January 31, 2024 | 2.228M |
December 31, 2023 | 2.228M |
December 26, 2023 | 2.228M |
December 20, 2023 | 1.987M |
November 01, 2023 | 1.987M |
September 30, 2023 | 1.987M |
August 23, 2023 | 1.987M |
August 21, 2023 | 1.987M |
August 01, 2023 | 1.987M |
June 30, 2023 | 1.986M |
May 01, 2023 | 1.978M |
March 31, 2023 | 1.973M |
March 27, 2023 | 1.968M |
March 14, 2023 | 1.908M |
December 31, 2022 | 1.908M |
November 03, 2022 | 1.908M |
September 30, 2022 | 1.908M |
August 01, 2022 | 1.907M |
June 30, 2022 | 1.907M |
Date | Value |
---|---|
May 04, 2022 | 1.905M |
March 31, 2022 | 1.905M |
March 28, 2022 | 1.905M |
March 14, 2022 | 1.905M |
December 31, 2021 | 1.905M |
November 03, 2021 | 1.905M |
September 30, 2021 | 1.905M |
August 03, 2021 | 1.904M |
June 30, 2021 | 1.904M |
June 25, 2021 | 1.904M |
June 24, 2021 | 1.896M |
May 13, 2021 | 1.896M |
May 04, 2021 | 1.896M |
March 31, 2021 | 1.896M |
March 29, 2021 | 1.896M |
March 11, 2021 | 1.896M |
February 10, 2021 | 1.895M |
February 05, 2021 | 1.752M |
February 02, 2021 | 0.8004M |
February 01, 2021 | 0.80M |
January 29, 2021 | 0.80M |
December 31, 2020 | 0.7691M |
November 11, 2020 | 0.6941M |
November 05, 2020 | 0.6941M |
September 30, 2020 | 0.6863M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.5022M
Minimum
Jun 30 2019
2.312M
Maximum
Mar 31 2024
1.502M
Average
1.904M
Median
Jun 25 2021
Shares Outstanding Benchmarks
Merck & Co Inc | 2.533B |
Lixte Biotechnology Holdings Inc | 2.249M |
Moderna Inc | 383.24M |
NovaBay Pharmaceuticals Inc | 1.081M |
Palatin Technologies Inc | 16.14M |